Pfizer's RSV vaccine to protect babies gets greenlight from FDA

https://www.npr.org/sections/health-shots/2023/08/21/ [login to see] /pfizers-rsv-vaccine-to-protect-babies-gets-greenlight-from-fda
The Food and Drug Administration has approved the first RSV vaccine for expectant mothers aimed at protecting their newborn babies.

Given during the third trimester of pregnancy, Pfizer's new shot – Abrysvo – protects infants from lower respiratory tract disease caused by RSV, or respiratory syncytial virus, through their first six months of life.

RSV is a common respiratory virus that usually results in mild symptoms, but can be serious in infants, young children and older adults. Each year, up to 80,000 children under 5 are hospitalized with RSV, according to the Centers for Disease Control and Prevention. That makes it the leading cause of hospitalization among infants.